Is autoimmune hepatitis on the rise?

Is autoimmune hepatitis on the rise?

By Craig Lammert, M.D., AIHA Executive Director One of the most common questions our members ask is “how common is AIH?” Unfortunately, it’s a challenging question, and the answer depends on which epidemiologic study you are reading. There is no doubt AIH is a...
An AIH Diagnosis During the Pandemic

An AIH Diagnosis During the Pandemic

Just as the COVID-19 pandemic was beginning in the United States in early 2020, Chicago-area resident Dave Richardson started to feel sluggish and tired all the time. He didn’t have much of an appetite and just didn’t feel like himself. His blood pressure ended up...
Vaccine Booster Updates

Vaccine Booster Updates

By the Autoimmune Hepatitis Association New recommendations for booster vaccines have been issued in the US for those who received the Moderna and Johnson & Johnson vaccines. Many AIH patients who received the Pfizer or Moderna vaccines have already received third...
Research Update: ALT Levels in AIH

Research Update: ALT Levels in AIH

By Craig Lammert, M.D., AIHA Executive Director Currently, the most important treatment goal for autoimmune hepatitis (AIH) is normal liver tests (AST and ALT) and IgG levels. These numbers are used by treating doctors as surrogates for AIH-related liver inflammation....